STOCK TITAN

Kraig Biocraft Laboratories Inc - KBLB STOCK NEWS

Welcome to our dedicated news page for Kraig Biocraft Laboratories (Ticker: KBLB), a resource for investors and traders seeking the latest updates and insights on Kraig Biocraft Laboratories.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kraig Biocraft Laboratories's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kraig Biocraft Laboratories's position in the market.

Rhea-AI Summary

Kraig Biocraft Laboratories, Inc. reports signing landmark agreements with the Lam Dong Agro-Forestry Research Experiment Center in Vietnam for rearing and breeding specialized silkworms. The agreements outline a collaborative effort to integrate the Company's silk technologies, with the LAREC providing insights and assistance in selective breeding of the BAM-1 parental strains for local conditions. This strengthens the collaboration between Kraig Labs and governmental agencies in South East Asia, expanding the Company's operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. (KBLB) has successfully completed the rearing of the first generation of its new BAM-1 parental strains during its spring production trial. The Company exceeded all expectations and control parameters for cocoon production, with the guidance of a top sericulture expert. The BAM-1 parental lines demonstrated excellent growth rates and robustness, paving the way for large-scale production. The Company is now focused on breeding the next generation of production hybrid silkworms to further scale up production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.18%
Tags
none
-
Rhea-AI Summary
Kraig Biocraft Laboratories announces the successful launch of spring production trials in Southeast Asia for its new BAM-1 hybrid, showing strong performance and health in silkworms. The Company's CEO oversees the trials directly, reporting zero instances of disease in the colony, attributing success to improved genetics and technology transfer. Dr. Nirmal Kumar's contribution enhances production potential, leading to a promising year for spider silk production.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
none
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. signs a significant agreement with the Vietnam Sericulture Association to enhance production capabilities and obtain intellectual property registration for its BAM-1 hybrid silkworm strain, strengthening collaboration and setting the stage for increased production levels over the next two years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.3%
Tags
none
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. comments on an innovative advancement in spider silk engineering by Rensselaer Polytechnic Institute. The project involves creating spider silk protein from waste plastics using a new strain of Pseudomonas bacteria. While still in early stages, this method shows promise in addressing plastic waste challenges and creating biodegradable silk proteins.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.51%
Tags
none
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces the addition of Dr. Nirmal Kumar, an expert in sericulture, to oversee spring production trials and launch of BAM-1 hybrid in Vietnam. Dr. Kumar's extensive experience in silkworm breeding and rearing brings valuable expertise to the Company's operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
none
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces senior management's travel to Vietnam to oversee spring production trials for recombinant spider silk. The Company aims for large-scale production, scouting production partners, and finalizing agreements for growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.55%
Tags
none
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. (KBLB) announces the preparation of a second business investment application in Vietnam to expand its operations. The company plans to submit the license application this month, in collaboration with Lam Dong Agro-Forestry Research and Experiment Center and Vietnam Sericulture Association. The new subsidiary, Prodigy Silk, will focus on advancing sericulture using the company's silk technology. The facility in Lam Dong Province is undergoing renovations for spring production trials, with CEO Kim Thompson emphasizing the strategic importance of this investment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.94%
Tags
none
-
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. achieves homozygosity for spider silk gene in parental strains for new BAM 1 hybrid production system, marking a significant milestone in commercializing recombinant spider silk technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
none
Rhea-AI Summary
Kraig Biocraft Laboratories, Inc. announces the creation of a premium yarn blending recombinant spider silk with Pima Cotton, showcasing vertical integration in textile markets. The company aims to target luxury apparel markets and expand into technical applications for spider silk materials.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Kraig Biocraft Laboratories Inc

OTC:KBLB

KBLB Rankings

KBLB Stock Data

85.41M
776.63M
25.21%
Other Chemical and Fertilizer Mineral Mining
Mining, Quarrying, and Oil and Gas Extraction
Link
United States
Ann Arbor

About KBLB

kraig biocraft laboratories, inc. (trading symbol: kblb) is a fully reporting biotechnology company focused on the development and commercialization of spider silks. as a reporting company, our annual and quarterly reports to the sec can be found on edgar and on this website. our investments in genetic research are targeted for product development and innovative near-term solutions to meet the practical problems of our world. our genetic engineering research has succeeded in developing what many considered to be the holy grail of material science: a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. we are moving rapidly to commercialize of our spider silk technology, which we believe will have a significant impact on the global textiles industry. at the same time we are continuing to work in cooperation with leading laboratories to create new stronger and more flexible spider silk based fibers with potentially broad appli